23
May

08:00 AM EDT

Bioinformatics

Strategy Meeting East Coast USA 2022

The premier meeting for all East Coast USA Bioinformatics professionals

Le Meridien Cambridge

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Bioinformatics Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered.

Proventa International’s R&D Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Bioinformatics professionals from across the East Coast, in Boston MA, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Become an official strategy meeting partner

Whatever you business needs, we can help. Get in touch for partnering opportunities

I’D LIKE TO PARTNER

Press play to hear what your colleagues had to say...

See the full agenda and facilitator line-up

Download the strategy meeting brochure for full details

DOWNLOAD THE BROCHURE

Meet Our 2022 Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Bioinformatics strategy meeting.

John McCarthy

VP, Field Applications BIOVIA, Dassault Systèmes

Kai Zhang

Director, Product Marketing BIOVIA, Dassault Systèmes

Luke Fisher

Global Leader, Biosciences Industry Process Consultants BIOVIA, Dassault Systèmes

Luke Fisher is the Global Leader for the Bioscience Industry Process Consultants at BIOVIA / Dassault Systèmes. His background brings more than twenty years of experience in scientific informatics solutions. Luke has domain knowledge across the scientific informatics industry including past leadership positions at BIOVIA / Dassault Systèmes, ACD/Labs, CDD, Perkin Elmer and Dotmatics. He have supported a broad range of industries including the world’s leading pharmaceutical, biotech, agricultural, chemicals, academic and government labs. Luke brings experience in scientific software solutions from the smaller scale deployment of point solutions (like molecular modeling packages) to the larger enterprise scale of ELNs, scientific workflow technologies, data content, analysis and visualization. In his current role, Luke and his group supports all global customers of laser focused on growth within the Design to Cure and Generative Therapeutics Design initiatives. He has a Ph.D. in computational chemistry from the University of Wisconsin Milwaukee.

David Crowley

Global Client Executive BIOVIA, Dassault Systèmes

Matt Harvey

Solution Sales Consultant BIOVIA, Dassault Systèmes

Mitchell Winfree

Sales Leader BIOVIA, Dassault Systèmes

Prof. Shai Shen-Orr

Co-founder and Chief Scientist CytoReason

Mike Waters

Vice President QuartzBio

Tim Sherbak

Product and Solutions Marketing Quantum

Dr. Chandra Sekhar Pedamallu

Vice President, Bioinformatics Excelra

Chandra Sekhar Pedamallu comes with extensive experience in Bioinformatics and Computational Biology specializing in cancer genomics. Before joining Excelra, Chandra was associated with Sanofi Inc., identifying novel drug targets in Oncology (Molecular and Immuno-oncology). Prior to Sanofi, he was at Dr. Meyerson Lab, Dana-Farber Cancer Institute, and a visiting scientist at The Broad Institute of MIT and Harvard. During his6-year tenure at Harvard, he led microbial analysis, pathogen discovery projects in cancer and other diseases. He has contributed substantially to over a dozen projects under the auspices of the Cancer Genome Atlas (TCGA).
Chandra holds a Ph.D. in Systems Engineering (area of research : Global Optimization) from School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore. He has co-authored over 85 manuscripts, published in highly reputed journals including Nature, Nature Genetics, Science, Cell, PNAS, etc., and has been inducted as a Fellow of the Royal Society of Biology (FRSB).

Garrick Myers

Head of Enterprise Customer Success Benchling

Nim Nadarajah

Partner, Advisory Services CrucialLogics

Amol Joshi

Partner, Enterprise Services CrucialLogics

Govinda Bhisetti

Vice President and Head of Computational Chemistry Cellarity

John Chan

Head Takeda ShinrAI Center for Artificial Intelligence/ Machine Learning

Clément Chatelain

Head Human Genetics and Genomics, Precision Medicine & Computational Biology Sanofi

Robert van den Berg

Head Data Sciences & Computational Vaccinology GSK

Hongyue Dai

Vice President, Translational Bioinformatics LifeMine Therapeutics

Hongyue Dai joined Cygnal Therapeutics in 2019. He formerly served as chief scientific officer (CSO) and chief bioinformatics officer (CBIO) at M2Gen, where he helped build the ORIEN, a cancer center network, to connect cancer hospitals with pharma companies for cancer research and drug development. While at M2Gen, Hongyue filed more than 10 patents on cancer prognosis models covering various cancer types.
Hongyue also served as Executive Director of Informatics & Analysis in Discovery & Preclinical Sciences at Merck Research Labs. He managed genomics and genetics projects to support all therapeutic franchises for target identification, biomarker discovery, compound prioritization, and translating biomarkers in clinical trials.
Prior to Merck, Hongyue was Research Associate Professor in the Physics Department at the University of Utah, where he analyzed and defended the highest energy cosmic ray particle, also known as the Oh-My-God or OMG particle. He then took on the role of Senior Data Analyst at Rosetta, where he co-developed the first microarray data error model to characterize the data uncertainty. He made significant contributions to the first FDA-approved multi-gene test kit for breast cancer prognosis, the MammaPrint. He also collaborated with Celera to develop the 14-gene test kit for ER-positive breast cancer patients.
Hongyue received his undergraduate degree in nuclear physics from Peking University and his Ph.D. in astrophysics from the Institute of High Energy Physics of the Chinese Academy of Science.

Piero Ricchiuto

Associate Director Bioinformatics, Computational Biology & Biomarker Discovery Alexion, AstraZeneca Rare Disease Unit

Piero holds a B.Sc, in Medical Biotechnology and M.Sc. in Bioinformatics obtained at the University of Milano-Bicocca (Italy).
Piero was privileged to work among the best academic’s labs around the world as Biotechnologist at San Raffaele Scientific Institute (Italy), PhD in Computational structural Biologist at the University of Leeds (UK) and a post-doc experience as Bioinformatician on -omics studies at Harvard Medical School of Boston (USA).
Piero spent last decade working in the R&D pharmaceutical industry providing bioinformatics solutions for drug development and biomarker discovery, most recently as Associate Director of Bioinformatics and Data Science at Alexion Pharmaceutical, AstraZeneca Rare Unit.
Piero’s research spans from the application of docking solutions/simulations for protein folding and protein-protein interactions, multi-omics network-based analysis aimed to MoA of small molecules, to targeted and untargeted clinical proteomics for biomarker discovery.

Panna Sharma

President & CEO Lantern Pharma

Artur Veloso

Head of Bioinformatics Repare Therapeutics

Gayle Wittenberg

VP Neuroscience Data Science and Digital Health Janssen R&D

Loren Perelman

Head of Enterprise Professional Services Benchling

First name	Last name	Job title	Company name	Photo URL	Bio Position
John	McCarthy	VP, Field Applications	BIOVIA, Dassault Systèmes	https://proventainternational.com/wp-content/uploads/2022/05/John-McCarthy.jpg
Kai	Zhang	Director, Product Marketing	BIOVIA, Dassault Systèmes	https://proventainternational.com/wp-content/uploads/2022/05/Kai-Zhang.jpg
Luke	Fisher	Global Leader, Biosciences Industry Process Consultants	BIOVIA, Dassault Systèmes	https://proventainternational.com/wp-content/uploads/2022/05/Luke-Fisher.jpg	Luke Fisher is the Global Leader for the Bioscience Industry Process Consultants at BIOVIA / Dassault Systèmes. His background brings more than twenty years of experience in scientific informatics solutions. Luke has domain knowledge across the scientific informatics industry including past leadership positions at BIOVIA / Dassault Systèmes, ACD/Labs, CDD, Perkin Elmer and Dotmatics. He have supported a broad range of industries including the world’s leading pharmaceutical, biotech, agricultural, chemicals, academic and government labs. Luke brings experience in scientific software solutions from the smaller scale deployment of point solutions (like molecular modeling packages) to the larger enterprise scale of ELNs, scientific workflow technologies, data content, analysis and visualization. In his current role, Luke and his group supports all global customers of laser focused on growth within the Design to Cure and Generative Therapeutics Design initiatives. He has a Ph.D. in computational chemistry from the University of Wisconsin Milwaukee.
David	Crowley	Global Client Executive	BIOVIA, Dassault Systèmes	https://proventainternational.com/wp-content/uploads/2022/05/David-Crowley.jpg
Matt	Harvey	Solution Sales Consultant	BIOVIA, Dassault Systèmes	https://proventainternational.com/wp-content/uploads/2022/05/Matt-Harvey.jpg
Mitchell	Winfree	Sales Leader	BIOVIA, Dassault Systèmes	https://proventainternational.com/wp-content/uploads/2020/01/silhouette2.png
Prof.	Shai Shen-Orr	Co-founder and Chief Scientist	CytoReason	https://proventainternational.com/wp-content/uploads/2021/09/Shai-Shen-Orr.jpg
Mike	Waters	Vice President	QuartzBio	https://proventainternational.com/wp-content/uploads/2021/09/Mike-Waters-2.png	Mike Waters collaborates with biopharmaceutical organizations to extract translational intelligence from the vast array of biomarker data collected across their drug development programs. Mike’s rich industry experience spans specialty lab services, IVD, and scaling technology-based solutions to top-40 pharma to help sponsors maintain visibility into sample collection, processing, and consent status across broad portfolios of studies.
Tim	Sherbak	Product and Solutions Marketing	Quantum	https://proventainternational.com/wp-content/uploads/2022/02/Tim-Sherbak.jpg
Dr.	Chandra Sekhar	Vice President, Bioinformatics	Excelra	https://proventainternational.com/wp-content/uploads/2022/04/Dr.-Chandra-Sekhar.jpg	Chandra Sekhar Pedamallu comes with extensive experience in Bioinformatics and Computational Biology specializing in cancer genomics. Before joining Excelra, Chandra was associated with Sanofi Inc., identifying novel drug targets in Oncology (Molecular and Immuno-oncology). Prior to Sanofi, he was at Dr. Meyerson Lab, Dana-Farber Cancer Institute, and a visiting scientist at The Broad Institute of MIT and Harvard. During his6-year tenure at Harvard, he led microbial analysis, pathogen discovery projects in cancer and other diseases. He has contributed substantially to over a dozen projects under the auspices of the Cancer Genome Atlas (TCGA). Chandra holds a Ph.D. in Systems Engineering (area of research : Global Optimization) from School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore. He has co-authored over 85 manuscripts, published in highly reputed journals including Nature, Nature Genetics, Science, Cell, PNAS, etc., and has been inducted as a Fellow of the Royal Society of Biology (FRSB).
Garrick	Myers	Head of Enterprise Customer Success	Benchling	https://proventainternational.com/wp-content/uploads/2022/04/Garrick-Myers.jpg
Nim	Nadarajah	Partner, Advisory Services	CrucialLogics	https://proventainternational.com/wp-content/uploads/2020/01/silhouette2.png
Amol	Joshi	Partner, Enterprise Services	CrucialLogics	https://proventainternational.com/wp-content/uploads/2022/04/Amol-Joshi.jpg
Govinda	Bhisetti	Vice President and Head of Computational Chemistry	Cellarity	https://proventainternational.com/wp-content/uploads/2020/08/Govinda-Bhisetti-1.jpg	Govinda Bhisetti got his Ph.D. from the Indian I at Vertex Pharmaceuticals Inc. in 1990 and worked in the Computational Sciences department for 22+ yenstitute of Science, Bangalore, in 1986. He joined the Scripps Research Institute in La Jolla, CA, as a postdoctoral fellow in 1987. His work at Scripps involved the use of Cray XMP supercomputers to simulate protein-ligand interactions and design novel inhibitors. From there, he went to workars, where he led molecular modeling and drug design efforts on several drug discovery projects. His research at Vertex led to the discovery of three FDA- approved drugs: two AIDS drugs, Agenerase (amprenavir) and Lexiva (fosamprenavir), and one hepatitis C drug, Incivek (Telaprevir). He is a co-inventor of these drugs and has been named an inventor on 26 patents. He published 72 research papers, including review articles and book chapters.
John	Chan	Head	Takeda ShinrAI Center for Artificial Intelligence/ Machine Learning	https://proventainternational.com/wp-content/uploads/2021/03/John-chan.jpeg	John is a technology executive, trained as a scientist and an engineer, with a 25-year career in data sciences. During this time, he built and led computational teams and pioneered innovation for global biopharma and biotech start-ups. Most recently, he built a computer vision-based AI company, Syllable Life Sciences, and as its CEO, led its acquisition by Neumora. Prior to his CEO role John held several management roles in computational biology, bioinformatics and enterprise IT, including time as an Executive Director and Head of Informatics, Technology and Program Innovation at Novartis. John earned a Ph.D. in genetics and molecular biology from the University of Pennsylvania.
Clément	Chatelain	Head Human Genetics and Genomics, Precision Medicine & Computational Biology	Sanofi	https://proventainternational.com/wp-content/uploads/2022/04/clement.png	Clement holds a PhD in Physics from the Ecole Normale Superieure in Paris. He conducted research at leading academic institutions including Massachusetts Institute of Technology, Cornell University, and INRIA (France) on various bioinformatic topics ranging from molecular modeling, systems biology, to disease modeling. Clement spent the last decade in the healthcare and pharmaceutical R&D industry. He has led translational projects in various therapeutic areas for new therapeutic target identification, biomarker discovery, and disease prioritization. He has a strong expertise in statistical genetics, systems biology, machine learning, and data lake infrastructures for omics data. He has been working with leading biobanks including UK Biobank and Finngen to mine real world evidence and genetic data to benefit therapeutic programs. At Sanofi he is currently leading statistical geneticists and data scientists to support precision medicine activities.
Robert	van den	Head Data Sciences & Computational Vaccinology	GSK	https://proventainternational.com/wp-content/uploads/2021/05/Robert-van-den-Berg.jpg
Hongyue	Dai	Vice President, Translational Bioinformatics	LifeMine Therapeutics	https://proventainternational.com/wp-content/uploads/2021/09/Hongyue-Dai-1.jpg	Hongyue Dai joined Cygnal Therapeutics in 2019. He formerly served as chief scientific officer (CSO) and chief bioinformatics officer (CBIO) at M2Gen, where he helped build the ORIEN, a cancer center network, to connect cancer hospitals with pharma companies for cancer research and drug development. While at M2Gen, Hongyue filed more than 10 patents on cancer prognosis models covering various cancer types. Hongyue also served as Executive Director of Informatics & Analysis in Discovery & Preclinical Sciences at Merck Research Labs. He managed genomics and genetics projects to support all therapeutic franchises for target identification, biomarker discovery, compound prioritization, and translating biomarkers in clinical trials. Prior to Merck, Hongyue was Research Associate Professor in the Physics Department at the University of Utah, where he analyzed and defended the highest energy cosmic ray particle, also known as the Oh-My-God or OMG particle. He then took on the role of Senior Data Analyst at Rosetta, where he co-developed the first microarray data error model to characterize the data uncertainty. He made significant contributions to the first FDA-approved multi-gene test kit for breast cancer prognosis, the MammaPrint. He also collaborated with Celera to develop the 14-gene test kit for ER-positive breast cancer patients. Hongyue received his undergraduate degree in nuclear physics from Peking University and his Ph.D. in astrophysics from the Institute of High Energy Physics of the Chinese Academy of Science.
Piero	Ricchiuto	Associate Director Bioinformatics, Computational Biology & Biomarker Discovery	Alexion, AstraZeneca Rare Disease Unit	https://proventainternational.com/wp-content/uploads/2022/03/Piero-Ricchiuto.jpg	Piero holds a B.Sc, in Medical Biotechnology and M.Sc. in Bioinformatics obtained at the University of Milano-Bicocca (Italy). Piero was privileged to work among the best academic’s labs around the world as Biotechnologist at San Raffaele Scientific Institute (Italy), PhD in Computational structural Biologist at the University of Leeds (UK) and a post-doc experience as Bioinformatician on -omics studies at Harvard Medical School of Boston (USA). Piero spent last decade working in the R&D pharmaceutical industry providing bioinformatics solutions for drug development and biomarker discovery, most recently as Associate Director of Bioinformatics and Data Science at Alexion Pharmaceutical, AstraZeneca Rare Unit. Piero’s research spans from the application of docking solutions/simulations for protein folding and protein-protein interactions, multi-omics network-based analysis aimed to MoA of small molecules, to targeted and untargeted clinical proteomics for biomarker discovery.
Panna	Sharma	President & CEO	Lantern Pharma	https://proventainternational.com/wp-content/uploads/2021/09/Panna-Sharma-scaled.jpg	Panna Sharma is the President and CEO of Lantern Pharma Inc. (LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR® AI and machine learning platform to transform and improve the cost, pace, and timeline of oncology drug discovery and development. As CEO, he led Lantern through its IPO in 2020 by implementing strategic initiatives to leverage AI and genomics to develop Lantern’s pipeline of precision oncology therapies and by working closely with venture investors to raise capital. Previously, Panna was President and CEO of Cancer Genetics, Inc (CGIX), and led them through their IPO in 2013. He started his career as an analyst and management consultant focused on healthcare and technology.
Artur	Veloso	Head of Bioinformatics	Repare Therapeutics	https://proventainternational.com/wp-content/uploads/2021/09/Artur-Veloso-e1631529344766.jpg	Artur Veloso trained as a bioinformatician at the University of Michigan, where he studied the dynamics of nascent RNA transcription. In 2014, he joined the Oncology Data Science group at the Novartis Institutes for BioMedical Research, where he supported pre-clinical and clinical immuno-oncology programs. In addition, he also spearheaded the characterization of the tumor microenvironment by applying deep learning approaches to digital pathology images. He joined Repare Therapeutics in 2018, an oncology drug discovery company focusing on identifying synthetic lethal partners through CRISPR screens. Currently, he heads the Bioinformatics team at Repare and is excited to have supported its growth from small biotech to two-compound clinical company. Although Artur trained as a data analyst, he is passionate about the development of bioinformatics tools to quickly bring solutions to biologists.
Gayle	Wittenberg	VP Neuroscience Data Science and Digital Health	Janssen R&D	https://proventainternational.com/wp-content/uploads/2021/09/Gayle-Wittenberg.jpeg	Gayle is Head of Neuroscience Data Science and Digital Health at Janssen R&D, integrating DS/DH end-to-end along the pharmaceutical value chain. She holds a PhD in Neuroscience from Princeton and B.S in Physics and B.S. in Engineering Physics from Oregon State. She worked in Proteomics at BMS and led the Personalized Healthcare group at Siemens Corporate Research before joining Janssen in 2011 as Director of Integrative Solutions. Subsequently she held positions as Head of Translational Research and Precision Medicine Research IT (2016) and Head Intelligent Automation Pharm IT (2019). Her focus is bringing the right medicine to the right patient.
Loren	Perelman	Head of Enterprise Professional Services	Benchling	https://proventainternational.com/wp-content/uploads/2022/03/loren-perelman.jpeg	Loren Perelman is Benchling’s Head of Enterprise Professional Services. His career has been focused on helping organizations make better use of their primary asset, data, by improving methods of collection and utilization. Prior to Benchling, Loren was VP of Scientific Solutions at Riffyn, working with various customers in the Biotech and Biopharma spaces. He has spent over a decade leading R&D, Process Development, and Manufacturing teams, with a focus on quality, analytical chemistry, and stats/modeling. He holds a PhD in Materials Science from UCSD and a B.S. in Chemistry from Harvey Mudd.

John McCarthy, Kai Zhang, Luke Fisher, David Crowley, Matt Harvey, Mitchell Winfree, Prof. Shai Shen-Orr, Mike Waters, Tim Sherbak, Dr. Chandra Sekhar Pedamallu, Garrick Myers, Nim Nadarajah, Amol Joshi, Govinda Bhisetti, John Chan, Clément Chatelain, Robert van den Berg, Hongyue Dai, Piero Ricchiuto, Panna Sharma, Artur Veloso, Gayle Wittenberg, Loren Perelman

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D Boston

Medicinal Chemistry Strategy Meeting East Coast – Boston 2024

Bioinformatics

Strategy Meeting East Coast USA 2022

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Le Meridien Cambridge

Fresh Bioinformatics Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Become an official strategy meeting partner

Press play to hear what your colleagues had to say...

See the full agenda and facilitator line-up

Meet Our 2022 Facilitators

John McCarthy

Kai Zhang

Luke Fisher

David Crowley

Matt Harvey

Mitchell Winfree

Prof. Shai Shen-Orr

Mike Waters

Tim Sherbak

Dr. Chandra Sekhar Pedamallu

Garrick Myers

Nim Nadarajah

Amol Joshi

Govinda Bhisetti

John Chan

Clément Chatelain

Robert van den Berg

Hongyue Dai

Piero Ricchiuto

Panna Sharma

Artur Veloso

Gayle Wittenberg

Loren Perelman

Our 2022 Lead Sponsor

Our 2022 Thought Leader

Our 2022 Co-Hosts

Here To Help

Want to find out more?

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Le Meridien Cambridge